Yes, CBD is processed by the liver. It undergoes extensive metabolism there, which is why only about 5% to 19% of an oral CBD dose actually reaches your bloodstream. This liver processing has real implications: it affects how much CBD your body can use, how it interacts with other medications, and whether high doses could stress the liver itself.
How the Liver Breaks Down CBD
When you swallow CBD, it travels through your digestive tract and into the liver before entering general circulation. This is called first-pass metabolism, and it’s the same process your liver uses to break down many drugs and supplements. The liver uses a family of enzymes to chemically transform CBD into smaller compounds your body can use or eliminate.
Three enzymes do most of the work. CYP2C19 and CYP2C9 convert CBD into its primary active metabolite, 7-hydroxy-CBD, which appears to be roughly as potent as CBD itself. CYP2C19 handles about 69% of this conversion, with CYP2C9 contributing the remaining 31%. A third enzyme, CYP3A4, breaks CBD down through different chemical pathways, producing several other metabolites. After the liver finishes processing CBD, about 33% of it leaves the body unchanged through feces, while the rest exits as modified compounds through both urine and feces.
Why So Little CBD Reaches Your Bloodstream
The liver’s first-pass metabolism is aggressive with CBD. Research in animal models found oral bioavailability averaging around 8.6%, with human estimates ranging from 5% to 19%. That means if you take 100 mg of CBD orally, somewhere between 5 mg and 19 mg actually makes it into your circulation to have an effect. The rest gets broken down by the liver or degraded in the gut before it ever reaches the rest of your body.
This is one reason CBD products taken under the tongue (sublingually) or inhaled tend to act faster and deliver more of the compound. These routes partially bypass the liver’s first pass. It’s also why some CBD products are formulated with fats or lipids: CBD is fat-soluble, and taking it with dietary fat can improve absorption through the gut, increasing the amount that ultimately reaches your bloodstream.
CBD Can Change How Your Liver Handles Other Drugs
CBD doesn’t just get processed by liver enzymes. It also inhibits them. This is the interaction that matters most if you take other medications. By slowing down the same enzymes that metabolize many common drugs, CBD can cause those drugs to build up to higher-than-intended levels in your body.
The enzymes CBD inhibits most strongly are CYP3A4, CYP2C19, CYP2D6, and CYP2C9. Together, these enzymes are responsible for metabolizing a huge number of prescription medications. Some notable categories include:
- Blood thinners: Warfarin is metabolized by CYP2C9. Higher warfarin levels increase bleeding risk.
- Anti-seizure medications: Clinical trials have shown CBD increases blood levels of clobazam and other epilepsy drugs. This is well-documented because pharmaceutical CBD is prescribed alongside these medications.
- Heart and blood pressure medications: Beta-blockers like metoprolol and propranolol, as well as certain cholesterol drugs like simvastatin and atorvastatin, rely on these same enzymes.
- Sedatives and psychiatric medications: Benzodiazepines like alprazolam, midazolam, and diazepam, plus antipsychotics like quetiapine, can all be affected.
- Common over-the-counter drugs: Even proton pump inhibitors like omeprazole and lansoprazole (used for acid reflux) are metabolized by CYP2C19.
For drugs with a narrow therapeutic window, where the difference between an effective dose and a toxic dose is small, this interaction can be clinically significant. Warfarin is the classic example: a small increase in blood levels can lead to dangerous bleeding. If you take any prescription medication regularly, the liver enzyme overlap with CBD is worth discussing with your pharmacist or prescriber.
Can CBD Damage the Liver?
At typical supplement doses, CBD does not appear to harm the liver. Studies of healthy adults taking around 50 mg per day for 30 days or longer showed no increase in liver enzyme levels compared to the general population. A trial in patients with Crohn’s disease found no liver function changes after eight weeks of 20 mg daily.
The concern arises at much higher doses. In clinical trials of pharmaceutical-grade CBD (Epidiolex) for epilepsy, doses starting at around 10 mg per kilogram of body weight per day, taken over 14 to 16 weeks, caused liver enzyme elevations greater than three times the normal upper limit in some participants. For a 150-pound person, that translates to roughly 680 mg per day. At 20 mg per kilogram per day (about 1,360 mg daily for that same person), elevations in multiple liver enzymes appeared within two to four weeks in several healthy subjects.
These are far above what most people take as a supplement. Typical consumer CBD doses range from 10 to 50 mg daily, though some people take considerably more. The dose-dependent pattern is clear: the risk of liver stress increases meaningfully once you cross into the hundreds of milligrams per day, particularly over weeks of continuous use.
People With Liver Disease Face Higher Risk
Because the liver is CBD’s primary processing site, existing liver impairment changes the equation. People with moderate or severe liver disease clear CBD more slowly, meaning the compound and its metabolites accumulate to higher levels. Pharmaceutical CBD dosing guidelines reflect this directly: for moderate liver impairment, recommended starting doses are cut roughly in half, and for severe impairment, they’re reduced to about one-quarter of the standard dose.
If you have any form of chronic liver disease, including fatty liver, hepatitis, or cirrhosis, your liver’s capacity to safely metabolize CBD is reduced. The same dose that causes no issues in someone with a healthy liver could produce higher blood levels and greater strain on already-compromised liver tissue.